Broedl UC - Search Results

1

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators. Zinman B, et al. Among authors: broedl uc. N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17. N Engl J Med. 2015. PMID: 26378978 Free article. Clinical Trial.

2

Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairment.

Macha S, Mattheus M, Halabi A, Pinnetti S, Woerle HJ, Broedl UC. Macha S, et al. Among authors: broedl uc. Diabetes Obes Metab. 2014 Mar;16(3):215-22. doi: 10.1111/dom.12182. Epub 2013 Aug 19. Diabetes Obes Metab. 2014. PMID: 23859488 Clinical Trial.

3

Pharmacokinetics, safety and tolerability of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with hepatic impairment.

Macha S, Rose P, Mattheus M, Cinca R, Pinnetti S, Broedl UC, Woerle HJ. Macha S, et al. Among authors: broedl uc. Diabetes Obes Metab. 2014 Feb;16(2):118-23. doi: 10.1111/dom.12183. Epub 2013 Aug 19. Diabetes Obes Metab. 2014. PMID: 23859534 Clinical Trial.

4

Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1).

Pieber TR, Famulla S, Eilbracht J, Cescutti J, Soleymanlou N, Johansen OE, Woerle HJ, Broedl UC, Kaspers S. Pieber TR, et al. Among authors: broedl uc. Diabetes Obes Metab. 2015 Oct;17(10):928-35. doi: 10.1111/dom.12494. Epub 2015 Jun 24. Diabetes Obes Metab. 2015. PMID: 26080652 Free PMC article. Clinical Trial.

5

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.

Chilton R, Tikkanen I, Cannon CP, Crowe S, Woerle HJ, Broedl UC, Johansen OE. Chilton R, et al. Among authors: broedl uc. Diabetes Obes Metab. 2015 Dec;17(12):1180-93. doi: 10.1111/dom.12572. Epub 2015 Oct 9. Diabetes Obes Metab. 2015. PMID: 26343814 Free PMC article. Clinical Trial.

6

Cardiovascular safety of empagliflozin in patients with type 2 diabetes: a meta-analysis of data from randomized placebo-controlled trials.

Salsali A, Kim G, Woerle HJ, Broedl UC, Hantel S. Salsali A, et al. Among authors: broedl uc. Diabetes Obes Metab. 2016 Oct;18(10):1034-40. doi: 10.1111/dom.12734. Epub 2016 Aug 24. Diabetes Obes Metab. 2016. PMID: 27376831 Free PMC article.

7

Pharmacokinetics of empagliflozin, a sodium glucose cotransporter-2 (SGLT2) inhibitor, and metformin following co-administration in healthy volunteers.

Macha S, Dieterich S, Mattheus M, Seman LJ, Broedl UC, Woerle HJ. Macha S, et al. Among authors: broedl uc. Int J Clin Pharmacol Ther. 2013 Feb;51(2):132-40. doi: 10.5414/CP201794. Int J Clin Pharmacol Ther. 2013. PMID: 23253948 Clinical Trial.

8

Effect of empagliflozin on the steady-state pharmacokinetics of ethinylestradiol and levonorgestrel in healthy female volunteers.

Macha S, Mattheus M, Pinnetti S, Woerle HJ, Broedl UC. Macha S, et al. Among authors: broedl uc. Clin Drug Investig. 2013 May;33(5):351-7. doi: 10.1007/s40261-013-0068-y. Clin Drug Investig. 2013. PMID: 23512637 Clinical Trial.

9

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™).

Zinman B, Inzucchi SE, Lachin JM, Wanner C, Ferrari R, Fitchett D, Bluhmki E, Hantel S, Kempthorne-Rawson J, Newman J, Johansen OE, Woerle HJ, Broedl UC. Zinman B, et al. Among authors: broedl uc. Cardiovasc Diabetol. 2014 Jun 19;13:102. doi: 10.1186/1475-2840-13-102. Cardiovasc Diabetol. 2014. PMID: 24943000 Free PMC article. Clinical Trial.

10

Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial.

Ridderstråle M, Andersen KR, Zeller C, Kim G, Woerle HJ, Broedl UC; EMPA-REG H2H-SU trial investigators. Ridderstråle M, et al. Among authors: broedl uc. Lancet Diabetes Endocrinol. 2014 Sep;2(9):691-700. doi: 10.1016/S2213-8587(14)70120-2. Epub 2014 Jun 16. Lancet Diabetes Endocrinol. 2014. PMID: 24948511 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page